Skin gel trial offers hope for easing fragile x symptoms
Symptom relief
Completed
This study tested whether a cannabidiol (CBD) gel applied to the skin could help reduce behavioral challenges in children and young adults with Fragile X Syndrome. Over 200 participants, aged 3 to under 30, were randomly assigned to receive either the active gel or a placebo gel …
Phase: PHASE3 • Sponsor: Zynerba Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Mar 12, 2026 13:50 UTC